デフォルト表紙
市場調査レポート
商品コード
1582708

摂取可能スマートピルの世界市場:業界分析、規模、シェア、成長、動向、予測(2024年~2031年)

Ingestible Smart Pills Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2031


出版日
ページ情報
英文 147 Pages
納期
2~5営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=152.30円
摂取可能スマートピルの世界市場:業界分析、規模、シェア、成長、動向、予測(2024年~2031年)
出版日: 2024年10月31日
発行: Persistence Market Research
ページ情報: 英文 147 Pages
納期: 2~5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

当レポートでは、世界の摂取可能スマートピル市場について調査し、成分別、用途別、エンドユーザー別、地域別動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 エグゼクティブサマリー

第2章 摂取可能スマートピル市場のイントロダクション

第3章 摂取可能スマートピル市場分析シナリオ

  • 価格分析
  • 市場と予測

第4章 摂取可能スマートピル市場力学

  • マクロ経済要因
  • 促進要因
  • 抑制要因
  • 機会
  • 動向
  • ポーターのファイブフォース分析
  • バリューチェーン分析

第5章 世界の摂取可能スマートピル市場分析と予測:成分別

  • イントロダクション
  • 摂取可能スマートピル市場予測:成分別
  • 市場の魅力分析:成分別

第6章 世界の摂取可能スマートピル市場分析と予測:用途別

  • イントロダクション
  • 摂取可能スマートピル市場予測:用途別
  • 市場の魅力分析:用途別

第7章 世界の摂取可能スマートピル市場分析と予測:エンドユーザー別

  • イントロダクション
  • 摂取可能スマートピル市場予測:エンドユーザー別
  • 摂取可能スマートピル市場の魅力分析:エンドユーザー別

第8章 世界の摂取可能スマートピル市場分析と予測:地域別

  • イントロダクション
  • 摂取可能スマートピル市場予測:地域別
  • 摂取可能スマートピル市場の魅力分析:地域別

第9章 北米の摂取可能スマートピル市場分析と予測

第10章 ラテンアメリカの摂取可能スマートピル市場分析と予測

第11章 欧州の摂取可能スマートピル市場分析と予測

第12章 アジア太平洋の摂取可能スマートピル市場分析と予測

第13章 中東・アフリカの摂取可能スマートピル市場分析と予測

第14章 競合情勢

  • 競合ダッシュボード
  • 企業プロファイル(詳細- 概要、財務、戦略、最近の動向)
  • 世界の市場参入企業
    • BodyCap-Medical
    • Philips Respironics
    • Given Imaging Ltd.
    • Olympus Corporation
    • Proteus Digital Health, Inc.
    • CapsoVision, Inc.
    • Chongqing Jinshan Science and Component(Group)Co., Ltd.
    • Medimetrics
    • IntroMedic Co., Ltd.
    • Check-Cap Ltd.
  • 使用される前提と頭字語
  • 調査手法
目次
Product Code: PMRREP14371

Persistence Market Research has recently released a comprehensive report on the global Ingestible Smart Pills market. This report provides an in-depth evaluation of critical market dynamics, including drivers, trends, opportunities, and challenges, delivering detailed insights into the market structure.

Key Insights:

  • Ingestible Smart Pills Market Size (2024E): USD 1,200.00 Mn
  • Projected Market Value (2031F): USD 1,852.60 Mn
  • Global Market Growth Rate (CAGR 2024 to 2031): 6.4%

Ingestible Smart Pills Market - Report Scope:

Ingestible smart pills represent a significant innovation in healthcare, offering a new approach to diagnosis, patient monitoring, and drug delivery. These tiny devices, ingested orally, are capable of gathering essential data from within the body, transmitting it externally for medical analysis. The primary application areas include gastrointestinal diagnostics, patient monitoring for chronic conditions, and real-time drug effectiveness evaluation. Market growth is primarily driven by the rising demand for minimally invasive diagnostic tools, advancements in sensor technology, and an aging population with increasing healthcare needs.

Market Growth Drivers:

The global Ingestible Smart Pills market is driven by several key factors, including the increasing prevalence of chronic gastrointestinal diseases, which fuels demand for non-invasive diagnostic and monitoring solutions. Advances in sensor technology and miniaturization enable the development of compact, efficient ingestible pills. Rising healthcare awareness and the emphasis on preventive care, along with the growth of digital health technologies, contribute to the market's expansion. The healthcare industry's shift towards personalized medicine also supports the adoption of smart pills, as these devices offer precise, patient-specific data that can guide treatment decisions.

Market Restraints:

Despite promising growth, the Ingestible Smart Pills market faces challenges such as high development and manufacturing costs, stringent regulatory requirements, and limited consumer awareness in emerging regions. The need for specialized facilities and technical expertise to manufacture these devices adds to the overall cost, potentially limiting accessibility. Furthermore, regulatory agencies demand rigorous testing for safety and efficacy, which can delay product launches and increase compliance costs. Privacy concerns surrounding patient data collected by ingestible pills may also hinder adoption, especially in regions with stringent data protection laws.

Market Opportunities:

The Ingestible Smart Pills market presents substantial opportunities with expanding applications across healthcare sectors. There is significant growth potential in new areas like personalized drug delivery and in-patient monitoring for cardiovascular and respiratory conditions. Collaborations between technology firms and healthcare providers could lead to novel solutions that further enhance patient outcomes. Additionally, advances in AI and machine learning could facilitate the development of more sophisticated analysis systems for data collected by ingestible pills, providing deeper insights and enabling predictive diagnostics. Emerging markets with growing healthcare infrastructure also present opportunities for expansion.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the Ingestible Smart Pills market globally?
  • Which application areas are leading in the adoption of ingestible smart pill technology?
  • How are advancements in sensor technology shaping the competitive landscape of the Ingestible Smart Pills market?
  • Who are the key players in the Ingestible Smart Pills market, and what strategies are they using to maintain competitiveness?
  • What are the emerging trends and future prospects in the global Ingestible Smart Pills market?

Competitive Intelligence and Business Strategy:

Key players in the global Ingestible Smart Pills market, including Proteus Digital Health, CapsoVision, and Medtronic, are focused on innovation, research, and strategic partnerships to maintain a competitive edge. Companies are investing in R&D to enhance the functionality and accessibility of smart pills, targeting improvements in battery life, data transmission capabilities, and patient comfort. Collaborations with healthcare providers, research institutions, and pharmaceutical companies enable them to extend their market reach and develop targeted solutions. Prioritizing compliance with regulatory standards and data security practices is crucial for fostering consumer trust and encouraging widespread adoption of smart pill technology.

Key Companies Profiled:

  • BodyCap-Medical
  • Philips Respironics
  • Given Imaging Ltd.
  • Olympus Corporation
  • Proteus Digital Health, Inc.
  • CapsoVision, Inc.
  • Chongqing Jinshan Science and Component (Group) Co., Ltd.
  • Medimetrics
  • IntroMedic Co., Ltd.
  • Check-Cap Ltd.
  • Others

Ingestible Smart Pills Industry Segmentation:

By Component

  • Smart Pills
  • Workstation

By Application

  • Imaging
  • Monitoring

By End User

  • Hospitals
  • Clinics
  • Research Institutes
  • Home Healthcare

By Region

  • North America
  • Europe
  • Latin America
  • APAC
  • MEA

Table of Contents

1. Executive Summary

2. Ingestible Smart Pills Market Introduction

  • 2.1. Market Definition
  • 2.2. Market Taxonomy
  • 2.3. Key Industry Developments

3. Ingestible Smart Pills Market Analysis Scenario

  • 3.1. Pricing Analysis
    • 3.1.1. Pricing Assumptions
    • 3.1.2. Price Projections Per Region
  • 3.2. Market Size (US$ Mn) and Forecast
    • 3.2.1. Market Size and Y-o-Y Growth
    • 3.2.2. Absolute $ Opportunity

4. Ingestible Smart Pills Market Dynamics

  • 4.1. Macro-economic Factors
  • 4.2. Drivers
  • 4.3. Restraints
  • 4.4. Opportunities
  • 4.5. Trends
  • 4.6. Porters Five Forces Analysis
  • 4.7. Value Chain Analysis

5. Global Ingestible Smart Pills Market Analysis and Forecast, By Component

  • 5.1. Introduction
    • 5.1.1. Basis Point Share (BPS) Analysis By Component
    • 5.1.2. Y-o-Y Growth Projections By Component
  • 5.2. Ingestible Smart Pills Market Size (US$ Mn) Forecast By Component
    • 5.2.1. Smart Pills
      • 5.2.1.1. Patient Monitoring
      • 5.2.1.2. Capsule Endoscopy
        • 5.2.1.2.1. Small Bowel Endoscopy
        • 5.2.1.2.2. Esophagus Endoscopy
        • 5.2.1.2.3. Colon Endoscopy
    • 5.2.2. Workstation
  • 5.3. Market Attractiveness Analysis By Component

6. Global Ingestible Smart Pills Market Analysis and Forecast, By Application

  • 6.1. Introduction
    • 6.1.1. Basis Point Share (BPS) Analysis By Application
    • 6.1.2. Y-o-Y Growth Projections By Application
  • 6.2. Ingestible Smart Pills Market Size (US$ Mn) Forecast By Application
    • 6.2.1. Imaging
    • 6.2.2. Monitoring
  • 6.3. Market Attractiveness Analysis By Application

7. Global Ingestible Smart Pills Market Analysis and Forecast, By End User

  • 7.1. Introduction
    • 7.1.1. Basis Point Share (BPS) Analysis By End User
    • 7.1.2. Y-o-Y Growth Projections By End User
  • 7.2. Ingestible Smart Pills Market Size (US$ Mn) Forecast By End User
    • 7.2.1. Hospitals
    • 7.2.2. Clinics
    • 7.2.3. Research Institutes
    • 7.2.4. Home Healthcare
  • 7.3. Ingestible Smart Pills Market Attractiveness Analysis By End User

8. Global Ingestible Smart Pills Market Analysis and Forecast, By Region

  • 8.1. Introduction
    • 8.1.1. Basis Point Share (BPS) Analysis By Region
    • 8.1.2. Y-o-Y Growth Projections By Region
  • 8.2. Ingestible Smart Pills Market Size (US$ Mn) Forecast By Region
    • 8.2.1. North America
    • 8.2.2. Latin America
    • 8.2.3. Europe
    • 8.2.4. Asia Pacific
    • 8.2.5. Middle East and Africa
  • 8.3. Ingestible Smart Pills Market Attractiveness Analysis By Region

9. North America Ingestible Smart Pills Market Analysis and Forecast

  • 9.1. Introduction
    • 9.1.1. Basis Point Share (BPS) Analysis By Country
    • 9.1.2. Y-o-Y Growth Projections By Country
    • 9.1.3. Key Regulations
  • 9.2. Ingestible Smart Pills Market Size (US$ Mn) Forecast By Country
    • 9.2.1. U.S.
    • 9.2.2. Canada
  • 9.3. Ingestible Smart Pills Market Size (US$ Mn) Forecast By Component
    • 9.3.1. Smart Pills
      • 9.3.1.1. Patient Monitoring
      • 9.3.1.2. Capsule Endoscopy
        • 9.3.1.2.1. Small Bowel Endoscopy
        • 9.3.1.2.2. Esophagus Endoscopy
        • 9.3.1.2.3. Colon Endoscopy
    • 9.3.2. Workstation
  • 9.4. Ingestible Smart Pills Market Size (US$ Mn) Forecast By Application
    • 9.4.1. Imaging
    • 9.4.2. Monitoring
  • 9.5. Ingestible Smart Pills Market Size (US$ Mn) Forecast By End User
    • 9.5.1. Hospitals
    • 9.5.2. Clinics
    • 9.5.3. Research Institutes
    • 9.5.4. Home Healthcare
  • 9.6. Market Attractiveness Analysis
    • 9.6.1. By Country
    • 9.6.2. By Component
    • 9.6.3. By Application
    • 9.6.4. By End User
  • 9.7. Prominent Trends
  • 9.8. Drivers and Restraints: Impact Analysis

10. Latin America Ingestible Smart Pills Market Analysis and Forecast

  • 10.1. Introduction
    • 10.1.1. Basis Point Share (BPS) Analysis By Country
    • 10.1.2. Y-o-Y Growth Projections By Country
    • 10.1.3. Key Regulations
  • 10.2. Ingestible Smart Pills Market Size (US$ Mn) Forecast By Country
    • 10.2.1. Brazil
    • 10.2.2. Mexico
    • 10.2.3. Rest of Latin America
  • 10.3. Ingestible Smart Pills Market Size (US$ Mn) Forecast By Component
    • 10.3.1. Smart Pills
      • 10.3.1.1. Patient Monitoring
      • 10.3.1.2. Capsule Endoscopy
        • 10.3.1.2.1. Small Bowel Endoscopy
        • 10.3.1.2.2. Esophagus Endoscopy
        • 10.3.1.2.3. Colon Endoscopy
    • 10.3.2. Workstation
  • 10.4. Ingestible Smart Pills Market Size (US$ Mn) Forecast By Application
    • 10.4.1. Imaging
    • 10.4.2. Monitoring
  • 10.5. Ingestible Smart Pills Market Size (US$ Mn) Forecast By End User
    • 10.5.1. Hospitals
    • 10.5.2. Clinics
    • 10.5.3. Research Institutes
    • 10.5.4. Home Healthcare
  • 10.6. Market Attractiveness Analysis
    • 10.6.1. By Country
    • 10.6.2. By Component
    • 10.6.3. By Application
    • 10.6.4. By End User
  • 10.7. Prominent Trends
  • 10.8. Drivers and Restraints: Impact Analysis

11. Europe Ingestible Smart Pills Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Basis Point Share (BPS) Analysis By Country / Region
    • 11.1.2. Y-o-Y Growth Projections By Country
    • 11.1.3. Key Regulations
  • 11.2. Ingestible Smart Pills Market Size (US$ Mn) Forecast By Country/Region
    • 11.2.1. Germany
    • 11.2.2. France
    • 11.2.3. Italy
    • 11.2.4. Spain
    • 11.2.5. U.K.
    • 11.2.6. Russia
    • 11.2.7. Rest of Western Europe
  • 11.3. Ingestible Smart Pills Market Size (US$ Mn) Forecast By Component
    • 11.3.1. Smart Pills
      • 11.3.1.1. Patient Monitoring
      • 11.3.1.2. Capsule Endoscopy
        • 11.3.1.2.1. Small Bowel Endoscopy
        • 11.3.1.2.2. Esophagus Endoscopy
        • 11.3.1.2.3. Colon Endoscopy
    • 11.3.2. Workstation
  • 11.4. Ingestible Smart Pills Market Size (US$ Mn) Forecast By Application
    • 11.4.1. Imaging
    • 11.4.2. Monitoring
  • 11.5. Ingestible Smart Pills Market Size (US$ Mn) Forecast By End User
    • 11.5.1. Hospitals
    • 11.5.2. Clinics
    • 11.5.3. Research Institutes
    • 11.5.4. Home Healthcare
  • 11.6. Market Attractiveness Analysis
    • 11.6.1. By Country
    • 11.6.2. By Component
    • 11.6.3. By Application
    • 11.6.4. By End User
  • 11.7. Prominent Trends
  • 11.8. Drivers and Restraints: Impact Analysis

12. Asia Pacific Ingestible Smart Pills Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Basis Point Share (BPS) Analysis By Country
    • 12.1.2. Y-o-Y Growth Projections By Country
    • 12.1.3. Key Regulations
  • 12.2. Ingestible Smart Pills Market Size (US$ Mn) Forecast By Country
    • 12.2.1. India
    • 12.2.2. China
    • 12.2.3. Australia and New Zealand
    • 12.2.4. ASEAN
    • 12.2.5. Rest of APEJ
  • 12.3. Ingestible Smart Pills Market Size (US$ Mn) Forecast By Component
    • 12.3.1. Smart Pills
      • 12.3.1.1. Patient Monitoring
      • 12.3.1.2. Capsule Endoscopy
        • 12.3.1.2.1. Small Bowel Endoscopy
        • 12.3.1.2.2. Esophagus Endoscopy
        • 12.3.1.2.3. Colon Endoscopy
    • 12.3.2. Workstation
  • 12.4. Ingestible Smart Pills Market Size (US$ Mn) Forecast By Application
    • 12.4.1. Imaging
    • 12.4.2. Monitoring
  • 12.5. Ingestible Smart Pills Market Size (US$ Mn) Forecast By End User
    • 12.5.1. Hospitals
    • 12.5.2. Clinics
    • 12.5.3. Research Institutes
    • 12.5.4. Home Healthcare
  • 12.6. Market Attractiveness Analysis
    • 12.6.1. By Country
    • 12.6.2. By Component
    • 12.6.3. By Application
    • 12.6.4. By End User
  • 12.7. Prominent Trends
  • 12.8. Drivers and Restraints: Impact Analysis

13. Middle East & Africa (MEA) Ingestible Smart Pills Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Basis Point Share (BPS) Analysis By Country
    • 13.1.2. Y-o-Y Growth Projections By Country
    • 13.1.3. Key Regulations
  • 13.2. Ingestible Smart Pills Market Size (US$ Mn) Forecast By Country
    • 13.2.1. GCC Countries
    • 13.2.2. South Africa
    • 13.2.3. Rest of MEA
  • 13.3. Ingestible Smart Pills Market Size (US$ Mn) Forecast By Component
    • 13.3.1. Smart Pills
      • 13.3.1.1. Patient Monitoring
      • 13.3.1.2. Capsule Endoscopy
        • 13.3.1.2.1. Small Bowel Endoscopy
        • 13.3.1.2.2. Esophagus Endoscopy
        • 13.3.1.2.3. Colon Endoscopy
    • 13.3.2. Workstation
  • 13.4. Ingestible Smart Pills Market Size (US$ Mn) Forecast By Application
    • 13.4.1. Imaging
    • 13.4.2. Monitoring
  • 13.5. Ingestible Smart Pills Market Size (US$ Mn) Forecast By End User
    • 13.5.1. Hospitals
    • 13.5.2. Clinics
    • 13.5.3. Research Institutes
    • 13.5.4. Home Healthcare
  • 13.6. Market Attractiveness Analysis
    • 13.6.1. By Country
    • 13.6.2. By Component
    • 13.6.3. By Application
    • 13.6.4. By End User
  • 13.7. Prominent Trends
  • 13.8. Drivers and Restraints: Impact Analysis

14. Competition Landscape

  • 14.1. Competition Dashboard
  • 14.2. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
  • 14.3. Global Players
    • 14.3.1. BodyCap-Medical
    • 14.3.2. Philips Respironics
    • 14.3.3. Given Imaging Ltd.
    • 14.3.4. Olympus Corporation
    • 14.3.5. Proteus Digital Health, Inc.
    • 14.3.6. CapsoVision, Inc.
    • 14.3.7. Chongqing Jinshan Science and Component (Group) Co., Ltd.
    • 14.3.8. Medimetrics
    • 14.3.9. IntroMedic Co., Ltd.
    • 14.3.10. Check-Cap Ltd.
  • 14.4. Assumptions and Acronyms Used
  • 14.5. Research Methodology